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Background: Cognitive Stimulation Therapy (CST) is a psychosocial evidence-based group intervention for people
with dementia recommended by the UK NICE guidelines. In clinical trials, CST has been shown to improve
cognition and quality of life, but little is known about the best way of ensuring implementation of CST in practice
settings. A recent pilot study found that a third of people who attend CST training go on to run CST in practice,
but staff identified a lack of support as a key reason for the lack of implementation.
Methods/design: There are three projects in this study: The first is a pragmatic multi-centre, randomised controlled
trial (RCT) of staff training, comparing CST training and outreach support with CST training only; the second, the
monitoring and outreach trial, is a phase IV trial that evaluates implementation of CST in practice by staff members
who have previously had the CST manual or attended training. Centres will be randomised to receive outreach
support. The primary outcome measure for both of these trials is the number of CST sessions run for people with
dementia. Secondary outcomes include the number of attenders at sessions, job satisfaction, dementia knowledge
and attitudes, competency, barriers to change, approach to learning and a controllability of beliefs and the level of
adherence. Focus groups will assess staff members’ perceptions of running CST groups and receiving outreach
support. The third study involves monitoring centres running groups in their usual practice and looking at basic
outcomes of cognition and quality of life for the person with dementia.
Discussion: These studies assess the effects of outreach support on putting CST into practice and running groups
effectively in a variety of care settings with people with dementia; evaluate the effectiveness of CST in standard
clinical practice; and identify key factors promoting or impeding the successful running of groups.
Trial registration: Clinical trial ISRCTN28793457.
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The worldwide population is rapidly aging [1], resulting
in increased numbers of people with dementia [2]. The
increase in demand for dementia-related services has
long been anticipated. However, the planning and
provision of services for people with dementia appear to
be failing to meet increasing requirements [3]. Two* Correspondence: a.streater@ucl.ac.uk
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reproduction in any medium, provided the orthirds of people living in care homes have dementia,
which in turn leads to an increasing level of dependency
that can be attributed to a lack of stimulation, increased
behavioural problems and the use of anti-psychotic
medication [4]. There is a need to provide services in
the community but also to improve the availability of
psychosocial interventions.
CST is an evidence-based group programme for
people with mild to moderate dementia [5]. A review of
reality orientation (RO) [6] helped to develop CST as a
brief psychosocial group intervention, focussing on im-
plicit information processing. The development of CSTl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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guidelines for the development and evaluation of com-
plex interventions [7]. Cognitive stimulation leads to
benefits in cognition and quality of life in the person
with dementia [8], is shown to be cost effective and
compares favourably with cholinesterase inhibitors for
Alzheimer’s disease [5,9]. Currently cognitive stimulation
is the only non-pharmacological intervention to improve
cognition recommended in the NICE-SCIE Guidelines
for Dementia [10], which recommend that all people
with mild to moderate dementia should be ‘given the op-
portunity to participate in a structured group cognitive
stimulation programme’.
CST is a twice-weekly, 7-week programme of stimulat-
ing 45-min group activities for people with dementia. A
pilot study [11] of CST with an additional 16 weeks of
once-weekly maintenance CST (MCST) sessions found a
continued improvement in cognitive function for the
people with dementia receiving maintenance CST. A
large-scale RCT of maintenance CST (24 weeks of once-
weekly sessions) versus CST only [12] has recently been
completed as part of the SHIELD (Support at Home
Interventions to Enhance Life in Dementia) project. The
programme includes 7 weeks of CST and a further
24 weeks of maintenance CST sessions.
In recent years there has been an increase in the
provision of CST, with around a third of the community
mental health teams in the UK reporting using it [13].
This has been facilitated by the publication of the CST
‘Making a difference’ manual and the maintenance CST
manual ‘Making a difference 2’ with a CST staff-training
DVD [14,15]. However, there has been little research on
the long-term implementation and evaluation of CST in
practice.
A recent study found that after attending a CST train-
ing course, one third of the staff went on to implement
CST groups in practice [16]. All staff members feltTable 1 Project overview
Title Training and outreach trial Monito
Aim To assess the effectiveness
of staff training and outreach
support
To asses
practice
support
Participants Dementia care staff Dement
No previous CST experience
or training
Previous
manual/
Number 120 120
Resources CST manual maintenance
CST manual DVD
CST ma
CST ma
Training Yes Variable
Outreach 50% 50%
Assessment timeframe Baseline, 6 and 12 months Baselineskilled enough to run the groups; however, they identi-
fied the need for management support, regular supervi-
sion, supervision from a specialist, online forums and
additional training as useful in starting and running
groups. Previous research into CST has reached phase
III of the MRC framework for complex interventions [7].
This research aims to study the long-term implementa-
tion of CST within two linked trials and conduct a phase
IV trial that will evaluate the effects of training, and the
effects of outreach support and the long-term effects of
CST in practice, and will help to understand the barriers
and facilitators related to implementing CST in practice.
Methods
Design
This study includes three projects. The training and out-
reach trial and the monitoring and outreach trial differ
in how staff members are recruited and in their previous
exposure to training in CST. The observational study fo-
cuses on the effects of CST on people with dementia in
the practice context. The three projects together will
provide evidence on the most effective way of facilitating
the implementation, uptake and effectiveness of the ap-
proach in a clinical context (see Table 1).
Training and outreach trial (TROU)
The design is a pragmatic, multi-centre, single-blind,
two treatment arm, randomised controlled trial. All par-
ticipants receive the training package as treatment as
usual (TAU) consisting of the 1-day CST training, train-
ing DVD, CST manual and maintenance CST manual.
Participants in the intervention group also receive out-
reach support (local coordinator, email support and on-
line forum). The sample is dementia care staff from
specialist and non-specialist dementia care settings. The
staff are cluster randomised according to place of work,
before the training day, to receive outreach support orring and outreach trial Observational study
s the implementation in
of CST and outreach
To assess the effectiveness of CST in
practice
ia care staff People with dementia
ly received CST
training
100
nual maintenance
nual DVD
CST manual maintenance CST
manual DVD
Variable
No
, 6 and 12 months Before and after CST (0, 7 or 0, 14 weeks)
and maintenance CST (31 or 38 weeks)
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the first before the training day and at 6 and 12 months
thereafter (Figure 1).
Recruitment
Recruitment to the trial includes staff from care homes,
day centres and NHS Trusts from various locations
across the UK. The trial is advertised through the Jour-
nal of Dementia Care, and the National Care forum and
referrals are made through the commercial CST training
day. The research team is then able to assess their eligi-
bility for participating in the research. Follow-ups will
also be made with centres that have expressed a previous
interest in CST or attending a CST training day.
Participants
Staff members are screened to ensure they meet the in-
clusion criteria: (1) adequate written and spoken English,
(2) able to complete online assessments at three different
time points, (3) have at least two other team members
with whom to run groups, (4) agreement from their
management to have 2 h set aside per week to run the
CST groups and 1 h following on from this for the 24-Inclusion criteria
Screened & con
Baseline Assessment (0/12 months) &
Interven
CST training day, CST manual, Ma
Cluster rando
Outreach support 
1st follow up assessm
2nd follow up assessm
Figure 1 Flow diagram of training and outreach trial and assessmentweek maintenance CST programme, and (5) are able to
provide between five to eight people with mild to mod-
erate dementia who are willing to participate and meet
the inclusion criteria (described in the observational
arm). A minimum of three staff members is recruited
per centre for logistical reasons of being able to consist-
ently run the groups. Up to 40 centres are needed to be
able to recruit the 120 staff members required for the
trial. Working on the premise of a 15% attrition rate, the
sample size will provide sufficient numbers for the staff
training outreach support/no outreach support to esti-
mate effect size and the feasibility of the trial. The attri-
tion rate is an estimation based on previous research
conducted in CST [12].
Training package
The CST and maintenance CST manual along with the
DVD are distributed to all staff members participating in
the trial. The CST ‘Making a difference’ manual describes
an evidence-based programme of group activities provid-
ing stimulation for people with mild to moderate demen-
tia based on the principles of person-centred care. The
maintenance CST manual, ‘Making a difference 2’, follows for staff met.
sent obtained
 socio-demographic information
tion 
intenance CST manuals & DVD
misation
ent (6/12 months)
ent (12/12 months)
No outreach support
schedule.
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structured programme of activities aimed at challenging
yet empowering the person with dementia and comes with
a staff-training DVD. The staff-training DVD comprises
an introduction by Dr Aimee Spector as to what CST
is, a table listing the order of the CST and mainten-
ance CST sessions. and key principles. In addition to
this, there is video footage of CST sessions with
people with dementia for staff to observe and discuss.
After each clip there are questions based on the key
principles to encourage reflective learning and discus-
sion. All staff members attend a CST training day.
The training comprises the different perspectives of
dementia, the main psychosocial approaches for de-
mentia, the development and evaluation of CST, the
session themes and examples of activities for sessions,
key principles, planning of sessions and the setting up
of a group, and reflective learning of issues that arise
when implementing and running groups. The training
uses learning methods such as role-play, small group
exercise and use of the training DVD, and time is
spent reflecting on the sessions and critically apprais-
ing how the session is run. Following on from the
training day, it is advised that each session be run
with two facilitators to enable them to jointly plan
and reflect on the session, and complete the attend-
ance and adherence forms together.
Randomisation
Cluster randomisation occurs prior to the staff attending
the CST training day to ensure that staff members from
the same centre receive the same level of support. The
allocation ratio for randomisation is 1:1, into either the
intervention or TAU. Randomisation is managed by
email to the North Wales Organization for Randomized
Trials in Health (NWORTH), which is an accredited
trials unit, specialising in pragmatic trials.
Treatment as usual
Staff members within centres that are randomized to the
control group deliver the CST as usual but without the
additional outreach support. This can vary between cen-
tres and has the variability to change over time, but the
training package offered to the intervention group will
also be available to those in the control group. There-
fore, the trial examines the additional effects of the out-
reach support.
Intervention
A pilot study conducted by our team identified that out-
reach support should consist of (1) an online forum, (2)
email support and (3) local supervision [16]. The online
forum is an online discussion site. It is accessible by user
name and password. The first time a person attempts toenter the site, an email is sent to a member of the re-
search team for approval in order to ensure they have
been randomised to the intervention group. The use of a
login allows us to record the number of people accessing
the service, and how many times. Staff members are able
to write up a variety of messages ranging from com-
ments on sessions, to questions and advice. A researcher,
who has extensive experience of CST and experience of
running groups, delivers the email support (Amy Streater)
and the service is made available as much as is needed
by the staff members. A person familiar with CST and
experience in running groups delivers the local supervi-
sion. The centre identifies the relevant person; however,
if this is not possible a member of the research team
provides the support. The role of the local supervisor is
to help with the setting up of the CST group and also
the practical issues that the staff members encounter
when attempting to run CST groups. The supervisor
records all the support given.
Primary outcome measure
The primary outcome measure is number of CST and
maintenance CST sessions run in the centre by the
follow-up at 31 weeks. This is recorded using the moni-
toring progress form located in the ‘Making a difference’
manual [14], which includes who was in attendance,
level of interest, communication, enjoyment and mood,
on a rating scale 1–5. This measure is being completed
at the end of each session from baseline to 31 weeks (in-
clusive of maintenance CST), until the maintenance
CST groups have been completed or until the groups
have been discontinued.
Secondary outcome measures
a) The level of adherence to the CST and maintenance
CST programme is measured by a adherence list
designed as part of the research. It is based on the 18
key principles as developed as part of the maintenance
CST programme [15]. The responses are reviewed by
a researcher to mark whether staff are adhering to the
key principles as laid out in the ‘Making a difference 2’
manual. Any ambiguity of responses given by the
participants will be discussed with another researcher
until a consensus is reached as to whether they are
adhering to the key principles.
b) Job satisfaction [17] is measured using the
Minnesota Satisfaction Questionnaire (MSQ). It is
made up of 100 questions and comprises 20
dimensions with five items per scale with a 5-point
Likert rating scale. The measure has adequate
internal reliability.
c) Staff members’ approach to dementia is measured
using the Approaches to Dementia Questionnaire
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person with dementia and the care they receive. The
scale has high validity and good reliability using
Cronbach’s α for its person-centeredness and
hopefulness subscales [18].
d) Knowledge is measured using the Dementia
Knowledge–20 (DK-20) [19]. There are 20 questions
for which there are five possible answers. The scale
has sufficient reliability and is administered at
baseline and final follow-up only.
e) Perceived sense of competence is measured using
the Sense of Competence in Dementia care–Staff
questionnaire (SCIDS) [20]. It comprises 17 items
categorised into four subscales: professionalism,
building relationships, care challenges and sustaining
personhood. The scale has good internal
consistency.
f ) Learning characteristics of staff are measured using
the brief Learning Transfer System Inventory (LTSI)
[16,21]. The constructs of the LTSI are validated
using common factor analysis [22,23]. The brief
form comprises of 16 questions that are categorized
into four major groups: trainee characteristics,
motivation, work environment and ability [22]. All
the items use five-point Likert-type scales from 1,
strongly disagree, to 5, strongly agree.
g) Barriers to change within the workplace are
measured using the Barriers to Change
Questionnaire (BARCQ) [24]. It comprises 19
questions focussing on: institutional constraints,
support from colleagues, philosophical opposition,
client dissatisfaction, interference and positive
factors. It also allows the addition of any further
comments.
h) The emotional and behavioural responses relating to
challenging behaviour presented by the person with
dementia are measured by the Controllability Beliefs
Scale [25]. The scale has 15 items based on a 5-point
scale. The height of the score establishes the belief
of the staff member in relation to the level of
control demonstrated by the person with dementia.
The scale has good internal reliability.
i) Focus groups with staff and managers will be
conducted in both the TROU and MONOU trial to
obtain qualitative data with regards to people’s
perception of running groups and outreach support.
They will run in a variety of care settings, and follow
a semi-structured interview schedule, using
inductive thematic analysis to code and analyse the
gathered data.
Consent
Staff members give informed consent and it is made
clear that they will be of no disadvantage if they choosenot to participate further at any stage during the trial.
Consent is also sought from a member of management
in order to give staff the optimum chance of carrying
out CST in their workplace. Ethical approval was
granted June 2011 by East London REC 3.
Blinding
Although staff members cannot be blinded to their alloca-
tion, all assessment data are completed online and inde-
pendently of the research team. Once the staff member has
completed the survey, an administrator on the SHIELD
programme team assigns all staff members a code for iden-
tification purposes to maintain anonymity throughout the
trial. The researcher administering the outreach support
has the contact details of the staff members but is unaware
of their individual code; hence they are blind in identifying
the staff members. However, it is common for participants
to inadvertently inform researchers of the strand of the
trial they have been allocated to. To reduce the risk of this,
once staff members are aware of their code it is empha-
sised that it is not to be discussed with any members of the
research team. This reminder is included in the email sent
by a member of the research team to complete the follow-
up assessments.
Monitoring and outreach trial (MONOU)
The design is a pragmatic, multi-centre, single-blind phase
IV trial. Participants are staff members from centres that
have previously purchased the CST ‘Making a difference’
manual or attended a CST training course. The staff mem-
bers are currently in possession of the CST manual or
attended CST training. In addition to this, they all receive
the maintenance CST manual and DVD. It is recorded
whether participants have the manual only or manual and
training. Centres are cluster randomised into outreach
support or no outreach support (Figure 2). The time
points for completing the questionnaire are the same as
the training and outreach trial. However, they also
complete a retrospective questionnaire on their use of
CST in practice prior to the research.
Recruitment
Recruitment of staff members who have purchased the
manual is based on referrals by Hawker publications. A
database of attendees generated from previously run
CST training days allows us to approach people who
have attended CST training. Staff members are then
contacted to determine if they are interested in partici-
pating in the study. A CST poster advertises the research
on the CST website (www.cstdementia.com), SHIELD
(www.ucl.ac.uk/shield), and through the Journal of De-
mentia Care. The project is also a UKCRN portfolio-
adopted study allowing NHS Trusts nationwide to be
Baseline Assessment (0/12 months) & socio-demographic information
Cluster randomisation
CST training/manual 
1st follow up assessment (6/12 months)
2nd follow up assessment (12/12 months)
CST Manual only
Outreach No outreach  
Inclusion criteria for staff met
Screened & consent gained
Provision of Maintenance CST Manual and DVD
Figure 2 Flow diagram of the monitoring and outreach trial and assessment schedule.
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their eligibility for participating in the research.
Participants
Participants are dementia care staff who have the CST
manual or attended the CST training day, and are able
to implement the CST programme once or twice weekly.
The screening and inclusion criteria match those for the
training and outreach study but a minimum of one staff
member can be recruited per centre.
Randomisation
Randomisation is identical to the TROU trial. Before ran-
domisation it is recorded who has the manual or manual
and training. At various time points during the recruit-
ment of the participants the centres are divided into two
clusters, taking into considerations the size of the centre
and type of previous training (manual vs. manual and
training). This matched pair of clusters is then independ-
ently cluster randomized to receive the intervention or
TAU by remote email service to N-WORTH. Because ofdiffering numbers per centre we will endeavour to keep
similar numbers in the control and experimental group,
with an allocation ratio for randomisation of 1:1, into ei-
ther the intervention or TAU group.Treatment as usual
Sites that are randomised to the control group deliver
the CST as usual. This can vary between centres and has
the variability to change over time. The trial examines
the additional effects of the outreach support and long-
term effect in practice.Intervention
The outreach support options are identical to those in
the training and monitoring study, with one difference:
to emulate CST in practice, staff members identify the
local supervisor, and if this is not possible, it is recorded
accordingly. All the staff members randomised to receive
outreach support are encouraged to use all the options
available to them, but they are not compulsory. The staff
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reach support options.
Primary outcome measure
The primary outcome is identical to the TROU trial.
However, due to the nature of the recruitment, in that
people are being recruited who have previously pur-
chased the ‘Making a difference’ manual or attended
CST training, it will be dependent on people’s interest in
taking part in the research. As a minimum of one staff
member can participate per centre; between 40 and 120
centres are required to recruit 120 staff members. This
figure also accounts for a 15% attrition rate.
Secondary outcome measures
The secondary outcome measures are identical to those
in the TROU trial.
Consent
Informed consent is gained from each staff member and
a member of management, and is identical to the train-
ing and outreach trial. Ethical approval was granted June
2011 by East London REC 3.
Blinding
The procedure for blinding is identical to the TROU trial.
Analyses
Training and outreach trial & Monitoring and outreach trial
A combined analysis making use of the results from the
training and outreach trial (120 participants) and the
monitoring and outreach trial (120 participants) will be
carried out. The primary outcome will be the mean
number of CST sessions offered per centre assuming the
intra-cluster correlation p to be 0.05. At the 6-month
primary end point based on 240 staff members (120 out-
reach vs. 120 control) in the outreach group, the mean
number of sessions offered is estimated to be 16 (SD 10)
and in the control group the mean number of sessions
offered is expected to be 12 (SD 10). Setting p at 0.05,
power at 0.8, with the effect size at 0.4, then 200 partici-
pants would be required to demonstrate a difference be-
tween the groups.
Using all the participants recruited across both trials
(TROU and MONO), a four-group comparison will also
be made. This will compare training and outreach sup-
port, training and no outreach support, manual only and
outreach, and manual only and no outreach support.
This will determine if there are differences between
these groups at 6 and 12 months.
Observational study of CST in practice
The design is a multi-centre, longitudinal observational
study with people with dementia. Sites that are currentlyrunning or in the process of setting up CST groups
complete minimal outcome measures at three time
points with people with dementia who are participating
in the CST and maintenance CST programme (Figure 3).
The measures are being completed before the group
starts (baseline), 7 or 14 weeks depending on how they
implement the CST programme (once or twice weekly),
and after the maintenance CST at 31 or 38 weeks. The
intervention is CST as routinely offered in the care set-
ting. The aim of this study is to determine whether
groups are running in practice and demonstrate the
positive findings for cognition and quality of life of life
for the person with dementia found in previous CST re-
search [5,11].
Recruitment
Centres that are running CST groups are approached,
and the staff asked to complete measures in cognition
and quality of life with the people with dementia taking
part in the groups. The centre type, level of staff experi-
ence and training are recorded. The centres are given
the maintenance CST manual and staff training DVD.
Recruited participants have a confirmed diagnosis of
mild to moderate dementia.
Participants
Centres that are currently running or setting up CST
groups are approached to participate in the observa-
tional study. Approximately 13 centres are needed to
provide us with 100 people with dementia and experi-
enced staff in dementia care. The person with dementia
will have (1) a score of between 0.5 and 2 on the Clinical
Dementia Rating scale [26] and (2) a diagnosis of de-
mentia, (3) adequate spoken and written English, (4) the
ability to participate in a ‘meaningful’ conversation and
(5) remain in a group for 45 min. Participants also need
(6) adequate eyesight and hearing, (7) to be able and
willing to give informed consent, and (8) able to
complete a cognition and quality of life measure at three
intervals over a year. If five to eight people with demen-
tia give informed consent to complete the minimal out-
come measures, with a staff member or researcher, the
centre is recruited in to the study and a letter explaining
their participation in the research is sent to their GP.
Training package
The staff members within the centres have the CST
manual or previously attended CST training, which
includes the CST manual. In addition the centre will re-
ceive the Maintenance CST manual and DVD.
Randomisation
This is a naturalistic study of CST in practice so people
with dementia who are about to start CST groups are
Sites approached and recruited.
People with dementia screened & consent obtained.
Baseline Assessment (0/31 (38) weeks) & socio-demographic information
Commence CST groups
1st follow up assessment ((7/31) or (14/38) weeks) after once or twice 
weekly run CST sessions
Maintenance CST commences
Maintenance CST finishes
2nd follow up assessment 31 weeks following on from CST programme
Figure 3 Flow diagram of observational study and assessment schedule.
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then assessed at three time points (0, 7 and 31 weeks or 0,
14 and 38 weeks) throughout their participation in the trial.
Outcome measures
The primary and secondary outcome measures for
people with dementia are completed at baseline (T0)
prior to the CST programme starting, then post CST
groups (T1) (at 7 or 14 weeks depending on whether
groups are implemented once or twice weekly). The final
follow-up will be completed 24 weeks after the mainten-
ance CST has commenced (T2). Socio-demographic in-
formation is collected about the person with dementia
including age, gender, race, diagnosis of dementia, type
of diagnosis and medication. Medication will be
recorded at each follow-up to mark any differences for
the duration of their participation in the trial.
a) The primary outcome is cognition as measured by
the Mini Mental State Examination (MMSE) [27].
The MMSE has a score of up to 30 points and is
widely used as a brief indicator of level of cognitive
impairment. It has good reliability and validity.b) The secondary outcome measure is quality of life as
measured by the Quality of Life-Alzheimer’s Disease
(QoL-AD) [28]. The QoL-AD is a 13-item scale
measuring different aspects of life. The scale totals
52 points and higher scores indicate better quality of
life. It has good internal consistency, validity and
reliability [28,29].Consent
It is expected that the participants are competent to pro-
vide informed consent to participate in the trial. The British
Psychological Society guidance on evaluation of capacity
will be adhered to. In addition, consent is an on-going
process as opposed to a one-off decision and this will be
continually monitored throughout the study. Mental Cap-
acity Act [30] guidance will also be applied where relevant,
such as when then a participant is no longer able to give
informed consent. A person’s preference can be indicated
by their initial willingness to participate in the trial. How-
ever, if any distress or discomfort is evident during the
study the person will be withdrawn. Ethical approval was
granted on June 2011 by East London REC 3.
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Blinding is unnecessary for the staff members and
researchers, as each person with dementia has the op-
portunity to participate in the CST and maintenance
CST programme and the staff members are completing
the assessment at each time point.
Analyses
Analysis will be a pre-post analysis based on intention to
treat, in that all collected data made available by the person
with dementia will be included, regardless of whether they
complete the programme or not. Imputation methods such
as the last observation carried forward are of limited use in
dementia, as there is the expectation of a gradual decline
and for participants to be lost through illness or death. A
linear regression model will be used where data are missing
in order to predict the missing value and impute the total
when possible. The sample size calculation accounts for
the number of people expected to be available at the study
end point. All participants are in receipt of the CST and
maintenance CST programme. Analysis will take into ac-
count the evaluation at 24 weeks after CST as the primary
end point. Secondary analysis will consider the effects im-
mediately following the CST programme. Age, gender, cho-
linesterase inhibitor and baseline scores on the two scales
being measured will be entered as covariates, together with
‘centre’ entered as a random factor.
Ethical arrangements
Risks and anticipated benefits for trial participants
There appear to be no documented harmful side effects
from participating in either CST training or in the run-
ning of the CST and maintenance CST programme, and
no adverse reactions are apparent. People with dementia
who have participated in previous CST groups consist-
ently report benefits of feelings of validation, self-worth
and overall enjoyment of the sessions [31]. Potential par-
ticipants, both staff members and people with dementia,
will be fully informed of the potential risks and benefits
of the project. A reporting procedure is in place to en-
sure that serious adverse events (SAEs) are reported to
the Chief Investigator. SAEs that are considered to be
related and unexpected are reported to the Multicentre
Research Ethics Committee and the trial Data Monitor-
ing and Ethics Committee.
Discussion
This project will pragmatically evaluate the effectiveness of
staff training and outreach support by increasing the deliv-
ery of CST in practice by outreach support intervention
both in new CST practitioners (TROU trial) and experi-
enced CST practitioners (MONOU trial). The NICE-SCIE
guidelines recommend CST, and this project aims to record
the uptake and delivery of CST in dementia settings, todetermine if it is easy to follow and replicable in practice.
The MONOU trial provides a naturalistic evaluation of
benefits of manual only versus manual and training in CST
implementation, and both the TROU and MONOU trial
will identify staff and situational factors that impede or fa-
cilitate CST implementation. One of the important
advances in this study is to measure the adherence by spe-
cific questions developed in direct relation to the key prin-
ciples that define CST as a therapy. It also allows the
research to demonstrate, on a large scale, the knowledge,
views and understanding, and approach of staff members
to dementia in a variety of care settings nationwide with
the secondary outcome measures. In relation to the obser-
vational study it provides an evaluation of the long-term
cognitive and quality-of-life benefits of CST and mainten-
ance CST in practice.
This study should provide definitive evidence of the ef-
fectiveness and feasibility of implementation of CST and
maintenance CST in a variety of care settings. This study
is likely to influence the availability, provisions and
uptake of CST and maintenance CST in the UK and
internationally, and may also impact on current evidence-
based guidelines and policies relating to dementia care.
Trial status
Ongoing
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